Lancet Oncology, The, ISSN 1470-2045, 2007, Volume 8, Issue 1, pp. 35 - 45
Summary Intradural spinal-cord tumours are an uncommon but important consideration in the differential diagnosis of patients with back pain, radicular pain,...
Hematology, Oncology and Palliative Medicine | FILUM TERMINALE | PROGNOSTIC-FACTORS | ONCOLOGY | INTRAMEDULLARY SUBEPENDYMOMA | POSTOPERATIVE RADIOTHERAPY | FOLLOW-UP | EPENDYMOMAS | OF-THE-LITERATURE | CAUDA-EQUINA | SURGICAL-TREATMENT | TUMORS | Spinal Cord Neoplasms - pathology | Humans | Spinal Cord Neoplasms - classification | Tumors | Pain | Reviews | sensorimotor system | Neurons | Parenchyma | Adjuvants | Differential diagnosis | Glial cells | sphincter | Metastases
Hematology, Oncology and Palliative Medicine | FILUM TERMINALE | PROGNOSTIC-FACTORS | ONCOLOGY | INTRAMEDULLARY SUBEPENDYMOMA | POSTOPERATIVE RADIOTHERAPY | FOLLOW-UP | EPENDYMOMAS | OF-THE-LITERATURE | CAUDA-EQUINA | SURGICAL-TREATMENT | TUMORS | Spinal Cord Neoplasms - pathology | Humans | Spinal Cord Neoplasms - classification | Tumors | Pain | Reviews | sensorimotor system | Neurons | Parenchyma | Adjuvants | Differential diagnosis | Glial cells | sphincter | Metastases
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 5, pp. 1060 - 1068
Purpose/Objective(s) Primary low-grade gliomas are common brain tumors of childhood, many of which require radiation therapy (RT) as definitive treatment....
Radiology | Hematology, Oncology and Palliative Medicine | MOYAMOYA SYNDROME | THERAPY | ONCOLOGY | CONFORMAL RADIOTHERAPY | ASTROCYTOMAS | STEREOTACTIC RADIOTHERAPY | HYPOTHALAMIC GLIOMAS | CHILDHOOD | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | OPTIC PATHWAY GLIOMA | BRAIN-TUMORS | CHILDREN | Organs at Risk - radiation effects | Age Factors | Humans | Proton Therapy - adverse effects | Brain Neoplasms - pathology | Child, Preschool | Brain Neoplasms - complications | Glioma - radiotherapy | Glioma - complications | Young Adult | Pituitary Gland - radiation effects | Neoplasm Grading | Glioma - pathology | Retrospective Studies | Spinal Cord Neoplasms - radiotherapy | Brain Neoplasms - mortality | Brain Neoplasms - radiotherapy | Child | Cognition - radiation effects | Optic Chiasm | Radiotherapy Dosage | Glioma - mortality | Treatment Outcome | Intelligence - radiation effects | Brain Neoplasms - drug therapy | Spinal Cord Neoplasms - drug therapy | Spinal Cord Neoplasms - complications | Disease-Free Survival | Spinal Cord Neoplasms - mortality | Adolescent | Hippocampus - radiation effects | Radiotherapy, Conformal - adverse effects | Spinal Cord Neoplasms - pathology | Proton Therapy - methods | Temporal Lobe - radiation effects | Glioma - drug therapy | Radiotherapy, Conformal - methods | Sects | Pediatrics | Medical colleges | Gliomas | Patient outcomes | Radiation | Children | Health aspects | Chemotherapy | Brain tumors | Radiotherapy | Cancer | GLIOMAS | HIPPOCAMPUS | PATIENTS | SPINAL CORD | INJURIES | RADIOLOGY AND NUCLEAR MEDICINE | PEDIATRICS | PROTON BEAMS | RADIATION DOSES | RADIOTHERAPY | CHEMOTHERAPY | HYPOTHALAMUS
Radiology | Hematology, Oncology and Palliative Medicine | MOYAMOYA SYNDROME | THERAPY | ONCOLOGY | CONFORMAL RADIOTHERAPY | ASTROCYTOMAS | STEREOTACTIC RADIOTHERAPY | HYPOTHALAMIC GLIOMAS | CHILDHOOD | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | OPTIC PATHWAY GLIOMA | BRAIN-TUMORS | CHILDREN | Organs at Risk - radiation effects | Age Factors | Humans | Proton Therapy - adverse effects | Brain Neoplasms - pathology | Child, Preschool | Brain Neoplasms - complications | Glioma - radiotherapy | Glioma - complications | Young Adult | Pituitary Gland - radiation effects | Neoplasm Grading | Glioma - pathology | Retrospective Studies | Spinal Cord Neoplasms - radiotherapy | Brain Neoplasms - mortality | Brain Neoplasms - radiotherapy | Child | Cognition - radiation effects | Optic Chiasm | Radiotherapy Dosage | Glioma - mortality | Treatment Outcome | Intelligence - radiation effects | Brain Neoplasms - drug therapy | Spinal Cord Neoplasms - drug therapy | Spinal Cord Neoplasms - complications | Disease-Free Survival | Spinal Cord Neoplasms - mortality | Adolescent | Hippocampus - radiation effects | Radiotherapy, Conformal - adverse effects | Spinal Cord Neoplasms - pathology | Proton Therapy - methods | Temporal Lobe - radiation effects | Glioma - drug therapy | Radiotherapy, Conformal - methods | Sects | Pediatrics | Medical colleges | Gliomas | Patient outcomes | Radiation | Children | Health aspects | Chemotherapy | Brain tumors | Radiotherapy | Cancer | GLIOMAS | HIPPOCAMPUS | PATIENTS | SPINAL CORD | INJURIES | RADIOLOGY AND NUCLEAR MEDICINE | PEDIATRICS | PROTON BEAMS | RADIATION DOSES | RADIOTHERAPY | CHEMOTHERAPY | HYPOTHALAMUS
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2014, Volume 50, Issue 13, pp. 2309 - 2318
Abstract Background Tumours of the central nervous system (CNS) represent a relatively rare but serious health burden. This study provides insight into the...
Hematology, Oncology and Palliative Medicine | Glioma | Glioblastoma | Central nervous system | Oligoastrocytoma | Survival | Astrocytoma | Ependymoma | Oligodendroglioma | Incidence | TRENDS | CANCER | LOW-GRADE GLIOMAS | BRAIN-TUMORS | ADJUVANT TEMOZOLOMIDE | PHASE-3 TRIAL | MALIGNANT GLIOMAS | CENTRAL-NERVOUS-SYSTEM | RADIOTHERAPY | ONCOLOGY | Glioma - mortality | Astrocytoma - epidemiology | Humans | Middle Aged | Netherlands - epidemiology | Brain Neoplasms - pathology | Male | Survival Rate | Glioma - epidemiology | Glioblastoma - epidemiology | Astrocytoma - pathology | Spinal Cord Neoplasms - mortality | Glioblastoma - pathology | Glioma - pathology | Female | Spinal Cord Neoplasms - pathology | Aged | Brain Neoplasms - mortality | Glioblastoma - mortality | Astrocytoma - mortality | Brain Neoplasms - epidemiology | Spinal Cord Neoplasms - epidemiology | Gliomas
Hematology, Oncology and Palliative Medicine | Glioma | Glioblastoma | Central nervous system | Oligoastrocytoma | Survival | Astrocytoma | Ependymoma | Oligodendroglioma | Incidence | TRENDS | CANCER | LOW-GRADE GLIOMAS | BRAIN-TUMORS | ADJUVANT TEMOZOLOMIDE | PHASE-3 TRIAL | MALIGNANT GLIOMAS | CENTRAL-NERVOUS-SYSTEM | RADIOTHERAPY | ONCOLOGY | Glioma - mortality | Astrocytoma - epidemiology | Humans | Middle Aged | Netherlands - epidemiology | Brain Neoplasms - pathology | Male | Survival Rate | Glioma - epidemiology | Glioblastoma - epidemiology | Astrocytoma - pathology | Spinal Cord Neoplasms - mortality | Glioblastoma - pathology | Glioma - pathology | Female | Spinal Cord Neoplasms - pathology | Aged | Brain Neoplasms - mortality | Glioblastoma - mortality | Astrocytoma - mortality | Brain Neoplasms - epidemiology | Spinal Cord Neoplasms - epidemiology | Gliomas
Journal Article
ACTA NEUROPATHOLOGICA, ISSN 0001-6322, 09/2015, Volume 130, Issue 3, pp. 435 - 437
GLIOBLASTOMA | HISTONE H3.3 | PATHOLOGY | NEUROSCIENCES | CLINICAL NEUROLOGY | Spinal Cord - metabolism | Humans | Middle Aged | Brain Neoplasms - pathology | Brain Neoplasms - genetics | Child, Preschool | Infant | Spinal Cord Neoplasms - metabolism | Brain Neoplasms - metabolism | Glioma - metabolism | Glioma - genetics | Young Adult | Histones - genetics | Neoplasm Grading | Spinal Cord - pathology | Glioma - pathology | Adolescent | Biomarkers, Tumor - metabolism | Adult | Spinal Cord Neoplasms - pathology | Mutation | Spinal Cord Neoplasms - genetics | Child | Infant, Newborn
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 12/2016, Volume 23, Issue S5, pp. 946 - 953
Sichuan is a province in the west of China with a population of 81.4 million. This is the first statistical report of central nervous system (CNS) tumors...
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | ONCOLOGY | EPIDEMIOLOGY | Adenoma - ethnology | Tibet - ethnology | Age Factors | Adenoma - epidemiology | Humans | Middle Aged | Spinal Cord Neoplasms - secondary | Brain Neoplasms - pathology | Child, Preschool | Infant | Male | Incidence | Young Adult | Brain Neoplasms - secondary | Meningioma - epidemiology | Nerve Sheath Neoplasms - pathology | Adult | Female | Meningioma - ethnology | Child | Glioblastoma - ethnology | Infant, Newborn | Spinal Cord Neoplasms - ethnology | Pituitary Neoplasms - epidemiology | Nerve Sheath Neoplasms - epidemiology | Pituitary Neoplasms - pathology | China - epidemiology | Glioblastoma - epidemiology | Meningioma - pathology | Glioblastoma - pathology | Adolescent | Sex Factors | Adenoma - pathology | Brain - pathology | Spinal Cord Neoplasms - pathology | Nerve Sheath Neoplasms - ethnology | Brain Neoplasms - epidemiology | Brain Neoplasms - ethnology | Spinal Cord Neoplasms - epidemiology | Gliomas | Analysis | Brain tumors | Central nervous system | Cancer
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | ONCOLOGY | EPIDEMIOLOGY | Adenoma - ethnology | Tibet - ethnology | Age Factors | Adenoma - epidemiology | Humans | Middle Aged | Spinal Cord Neoplasms - secondary | Brain Neoplasms - pathology | Child, Preschool | Infant | Male | Incidence | Young Adult | Brain Neoplasms - secondary | Meningioma - epidemiology | Nerve Sheath Neoplasms - pathology | Adult | Female | Meningioma - ethnology | Child | Glioblastoma - ethnology | Infant, Newborn | Spinal Cord Neoplasms - ethnology | Pituitary Neoplasms - epidemiology | Nerve Sheath Neoplasms - epidemiology | Pituitary Neoplasms - pathology | China - epidemiology | Glioblastoma - epidemiology | Meningioma - pathology | Glioblastoma - pathology | Adolescent | Sex Factors | Adenoma - pathology | Brain - pathology | Spinal Cord Neoplasms - pathology | Nerve Sheath Neoplasms - ethnology | Brain Neoplasms - epidemiology | Brain Neoplasms - ethnology | Spinal Cord Neoplasms - epidemiology | Gliomas | Analysis | Brain tumors | Central nervous system | Cancer
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2007, Volume 63, Issue 1, pp. 81 - 89
Abstract Ependymomas are rare tumours of neuroectodermal origin classified as myxopapillary ependymoma and subependymoma (grade I), ependymoma (grade II) and...
Hematology, Oncology and Palliative Medicine | Ependymomas | Treatment | Prognosis | treatment | MOLECULAR-GENETIC ANALYSIS | PROGNOSTIC-FACTORS | POSTERIOR-FOSSA EPENDYMOMAS | SPINAL-CORD EPENDYMOMAS | MALIGNANT BRAIN-TUMORS | CHOROID-PLEXUS TUMORS | prognosis | ependymomas | RADIATION-THERAPY | ONCOLOGY | NERVOUS-SYSTEM TUMORS | CHILDRENS CANCER GROUP | HEMATOLOGY | INTRACRANIAL EPENDYMOMA | Ependymoma - etiology | Age Distribution | Brain Neoplasms - etiology | Humans | Brain Neoplasms - pathology | Male | Spinal Cord Neoplasms - metabolism | Glial Fibrillary Acidic Protein - metabolism | Brain Neoplasms - metabolism | Brain Neoplasms - surgery | Incidence | Infratentorial Neoplasms - metabolism | Ependymoma - diagnosis | Infratentorial Neoplasms - epidemiology | Infratentorial Neoplasms - etiology | Spinal Cord Neoplasms - surgery | Ependymoma - pathology | Female | Spinal Cord Neoplasms - radiotherapy | Brain Neoplasms - radiotherapy | Ependymoma - epidemiology | Infratentorial Neoplasms - radiotherapy | Brain Neoplasms - diagnosis | Risk Factors | Neoplasm Recurrence, Local | Spinal Cord Neoplasms - etiology | Infratentorial Neoplasms - pathology | Ependymoma - metabolism | Ependymoma - surgery | Sex Factors | Spinal Cord Neoplasms - diagnosis | Survival Analysis | Infratentorial Neoplasms - surgery | Spinal Cord Neoplasms - pathology | Neoplasm Staging | Ependymoma - radiotherapy | Infratentorial Neoplasms - diagnosis | Brain Neoplasms - epidemiology | Spinal Cord Neoplasms - epidemiology | Chemotherapy | Cancer | Tumors
Hematology, Oncology and Palliative Medicine | Ependymomas | Treatment | Prognosis | treatment | MOLECULAR-GENETIC ANALYSIS | PROGNOSTIC-FACTORS | POSTERIOR-FOSSA EPENDYMOMAS | SPINAL-CORD EPENDYMOMAS | MALIGNANT BRAIN-TUMORS | CHOROID-PLEXUS TUMORS | prognosis | ependymomas | RADIATION-THERAPY | ONCOLOGY | NERVOUS-SYSTEM TUMORS | CHILDRENS CANCER GROUP | HEMATOLOGY | INTRACRANIAL EPENDYMOMA | Ependymoma - etiology | Age Distribution | Brain Neoplasms - etiology | Humans | Brain Neoplasms - pathology | Male | Spinal Cord Neoplasms - metabolism | Glial Fibrillary Acidic Protein - metabolism | Brain Neoplasms - metabolism | Brain Neoplasms - surgery | Incidence | Infratentorial Neoplasms - metabolism | Ependymoma - diagnosis | Infratentorial Neoplasms - epidemiology | Infratentorial Neoplasms - etiology | Spinal Cord Neoplasms - surgery | Ependymoma - pathology | Female | Spinal Cord Neoplasms - radiotherapy | Brain Neoplasms - radiotherapy | Ependymoma - epidemiology | Infratentorial Neoplasms - radiotherapy | Brain Neoplasms - diagnosis | Risk Factors | Neoplasm Recurrence, Local | Spinal Cord Neoplasms - etiology | Infratentorial Neoplasms - pathology | Ependymoma - metabolism | Ependymoma - surgery | Sex Factors | Spinal Cord Neoplasms - diagnosis | Survival Analysis | Infratentorial Neoplasms - surgery | Spinal Cord Neoplasms - pathology | Neoplasm Staging | Ependymoma - radiotherapy | Infratentorial Neoplasms - diagnosis | Brain Neoplasms - epidemiology | Spinal Cord Neoplasms - epidemiology | Chemotherapy | Cancer | Tumors
Journal Article
Brain Pathology, ISSN 1015-6305, 01/2018, Volume 28, Issue 1, pp. 103 - 111
Ganglioglioma (GG) is a grade I tumor characterized by alterations in the MAPK pathway, including BRAF V600E mutation. Recently, diffuse midline glioma with an...
BRAF V600E | ganglioglioma | midline | H3 K27M | TUMOR RECURRENCE | INTRINSIC PONTINE GLIOMA | H3F3A | SUBGROUPS | PATHOLOGY | NEUROSCIENCES | CLINICAL NEUROLOGY | FEATURES | POSTERIOR-FOSSA | MOLECULAR CLASSIFICATION | BRAF(V600E) MUTATION | PILOCYTIC ASTROCYTOMA | GENETIC ALTERATIONS | Proteins | Pediatrics | Genetic aspects | Gene mutations | Gliomas | Brain tumors | Brain | Brain cancer | MAP kinase | Patients | Neuronal-glial interactions | Glioma | Quality | Fatalities | Mutation | Diagnosis | Histone H3 | Tumors | Life Sciences | Human health and pathology | Neurons and Cognition | Neurobiology | Genetics | Human genetics | Cancer
BRAF V600E | ganglioglioma | midline | H3 K27M | TUMOR RECURRENCE | INTRINSIC PONTINE GLIOMA | H3F3A | SUBGROUPS | PATHOLOGY | NEUROSCIENCES | CLINICAL NEUROLOGY | FEATURES | POSTERIOR-FOSSA | MOLECULAR CLASSIFICATION | BRAF(V600E) MUTATION | PILOCYTIC ASTROCYTOMA | GENETIC ALTERATIONS | Proteins | Pediatrics | Genetic aspects | Gene mutations | Gliomas | Brain tumors | Brain | Brain cancer | MAP kinase | Patients | Neuronal-glial interactions | Glioma | Quality | Fatalities | Mutation | Diagnosis | Histone H3 | Tumors | Life Sciences | Human health and pathology | Neurons and Cognition | Neurobiology | Genetics | Human genetics | Cancer
Journal Article
Neurosurgery, ISSN 0148-396X, 02/2011, Volume 68, Issue 2, pp. 302 - 309
BACKGROUND: Spinal cord tumors account for 5% to 10% of all primary central nervous system tumors. The most common intramedullary neoplasms are ependymomas,...
Microsurgery | Myxopapillary ependymoma | McCormick grade | Spinal ependymoma | SURGERY | MANAGEMENT | MYXOPAPILLARY EPENDYMOMAS | POSTOPERATIVE RADIOTHERAPY | ADULTS | RADIATION | CLINICAL NEUROLOGY | PREDICTORS | SURGICAL RESECTION | RETROSPECTIVE ANALYSIS | Prognosis | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Recovery of Function | Young Adult | Disease-Free Survival | Spinal Cord Neoplasms - mortality | Ependymoma - surgery | Ependymoma - mortality | Adolescent | Aged, 80 and over | Spinal Cord Neoplasms - surgery | Adult | Ependymoma - pathology | Female | Spinal Cord Neoplasms - pathology | Aged | Child | Spinal cord | Patients | Medical prognosis | Surgery | Tumors
Microsurgery | Myxopapillary ependymoma | McCormick grade | Spinal ependymoma | SURGERY | MANAGEMENT | MYXOPAPILLARY EPENDYMOMAS | POSTOPERATIVE RADIOTHERAPY | ADULTS | RADIATION | CLINICAL NEUROLOGY | PREDICTORS | SURGICAL RESECTION | RETROSPECTIVE ANALYSIS | Prognosis | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Recovery of Function | Young Adult | Disease-Free Survival | Spinal Cord Neoplasms - mortality | Ependymoma - surgery | Ependymoma - mortality | Adolescent | Aged, 80 and over | Spinal Cord Neoplasms - surgery | Adult | Ependymoma - pathology | Female | Spinal Cord Neoplasms - pathology | Aged | Child | Spinal cord | Patients | Medical prognosis | Surgery | Tumors
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 6/2009, Volume 93, Issue 2, pp. 205 - 212
Background Leptomeningeal metastasis (LM) occurs in 4–15% of patients with solid tumors. Although the clinical outcomes in cancer patients have been improving...
Intrathecal chemotherapy | Medicine & Public Health | MRI | Prognostic factor | Oncology | Leptomeningeal metastasis | Cancer | DIAGNOSIS | METHOTREXATE | CYTOLOGY | CHEMOTHERAPY | CLINICAL NEUROLOGY | BREAST-CANCER | MENINGEAL CARCINOMATOSIS | ONCOLOGY | DISEASE | CARCINOMATOUS MENINGITIS | NEOPLASTIC MENINGITIS | Prognosis | Lung Neoplasms - mortality | Humans | Middle Aged | Spinal Cord Neoplasms - secondary | Brain Neoplasms - pathology | Lung Neoplasms - pathology | Male | Stomach Neoplasms - pathology | Young Adult | Brain Neoplasms - secondary | Meningeal Neoplasms - drug therapy | Time Factors | Aged, 80 and over | Adult | Female | Retrospective Studies | Brain Neoplasms - mortality | Meningeal Neoplasms - mortality | Neoplasms - drug therapy | Breast Neoplasms - pathology | Neoplasm Metastasis - pathology | Survival Analysis | Breast Neoplasms - mortality | Spinal Cord Neoplasms - pathology | Aged | Meningeal Neoplasms - pathology | Neoplasms - pathology | Stomach Neoplasms - mortality | Meningeal Neoplasms - secondary | Care and treatment | Chemotherapy | Lung cancer | Patient outcomes | Metastasis | Universities and colleges
Intrathecal chemotherapy | Medicine & Public Health | MRI | Prognostic factor | Oncology | Leptomeningeal metastasis | Cancer | DIAGNOSIS | METHOTREXATE | CYTOLOGY | CHEMOTHERAPY | CLINICAL NEUROLOGY | BREAST-CANCER | MENINGEAL CARCINOMATOSIS | ONCOLOGY | DISEASE | CARCINOMATOUS MENINGITIS | NEOPLASTIC MENINGITIS | Prognosis | Lung Neoplasms - mortality | Humans | Middle Aged | Spinal Cord Neoplasms - secondary | Brain Neoplasms - pathology | Lung Neoplasms - pathology | Male | Stomach Neoplasms - pathology | Young Adult | Brain Neoplasms - secondary | Meningeal Neoplasms - drug therapy | Time Factors | Aged, 80 and over | Adult | Female | Retrospective Studies | Brain Neoplasms - mortality | Meningeal Neoplasms - mortality | Neoplasms - drug therapy | Breast Neoplasms - pathology | Neoplasm Metastasis - pathology | Survival Analysis | Breast Neoplasms - mortality | Spinal Cord Neoplasms - pathology | Aged | Meningeal Neoplasms - pathology | Neoplasms - pathology | Stomach Neoplasms - mortality | Meningeal Neoplasms - secondary | Care and treatment | Chemotherapy | Lung cancer | Patient outcomes | Metastasis | Universities and colleges
Journal Article
Journal of Neurosurgery, ISSN 0022-3085, 01/2003, Volume 98, Issue 1, pp. 82 - 94
Object. The goals of this study were to define the natural history and growth pattern of hemangioblastomas of the central nervous system (CNS) that are...
Neoplasm | Hemangioblastoma | Central nervous system | Von Hippel-Lindau disease | SURGERY | von Hippel-Lindau disease | TUMOR-SUPPRESSOR GENE | PHENOTYPE | hemangioblastoma | RADIOSURGERY | CLINICAL-FEATURES | IDENTIFICATION | CLINICAL NEUROLOGY | central nervous system | FAMILIES | GERMLINE MUTATIONS | neoplasm | GROWTH-FACTOR | RECEPTORS | EXPRESSION | Predictive Value of Tests | Follow-Up Studies | Outcome Assessment (Health Care) | Brain Stem Neoplasms - pathology | Hemangioblastoma - etiology | Humans | Cerebellar Neoplasms - etiology | Male | Spinal Cord Neoplasms - physiopathology | von Hippel-Lindau Disease - complications | von Hippel-Lindau Disease - pathology | Brain Stem Neoplasms - physiopathology | Time Factors | Adult | Female | Retrospective Studies | Cerebellar Neoplasms - pathology | Cerebellar Neoplasms - physiopathology | Severity of Illness Index | Supratentorial Neoplasms - etiology | Supratentorial Neoplasms - pathology | Supratentorial Neoplasms - physiopathology | Brain Stem Neoplasms - etiology | Spinal Cord Neoplasms - etiology | von Hippel-Lindau Disease - physiopathology | Hemangioblastoma - physiopathology | Magnetic Resonance Imaging | Hemangioblastoma - pathology | Spinal Cord Neoplasms - pathology
Neoplasm | Hemangioblastoma | Central nervous system | Von Hippel-Lindau disease | SURGERY | von Hippel-Lindau disease | TUMOR-SUPPRESSOR GENE | PHENOTYPE | hemangioblastoma | RADIOSURGERY | CLINICAL-FEATURES | IDENTIFICATION | CLINICAL NEUROLOGY | central nervous system | FAMILIES | GERMLINE MUTATIONS | neoplasm | GROWTH-FACTOR | RECEPTORS | EXPRESSION | Predictive Value of Tests | Follow-Up Studies | Outcome Assessment (Health Care) | Brain Stem Neoplasms - pathology | Hemangioblastoma - etiology | Humans | Cerebellar Neoplasms - etiology | Male | Spinal Cord Neoplasms - physiopathology | von Hippel-Lindau Disease - complications | von Hippel-Lindau Disease - pathology | Brain Stem Neoplasms - physiopathology | Time Factors | Adult | Female | Retrospective Studies | Cerebellar Neoplasms - pathology | Cerebellar Neoplasms - physiopathology | Severity of Illness Index | Supratentorial Neoplasms - etiology | Supratentorial Neoplasms - pathology | Supratentorial Neoplasms - physiopathology | Brain Stem Neoplasms - etiology | Spinal Cord Neoplasms - etiology | von Hippel-Lindau Disease - physiopathology | Hemangioblastoma - physiopathology | Magnetic Resonance Imaging | Hemangioblastoma - pathology | Spinal Cord Neoplasms - pathology
Journal Article
Journal of Neurosurgery: Spine, ISSN 1547-5654, 06/2018, Volume 28, Issue 6, pp. 642 - 646
Astroblastoma is a rare tumor that is thought to occur exclusively in the cerebrum. To the authors' knowledge, no cases of spinal cord astroblastoma have been...
Oncology | Astroblastoma | Spinal cord | Temozolomide | Radiation | Bevacizumab | Neoplasms, Neuroepithelial - therapy | Young Adult | Neoplasms, Neuroepithelial - diagnosis | Diagnosis, Differential | Humans | Spinal Cord Neoplasms - diagnosis | Female | Spinal Cord Neoplasms - pathology | Combined Modality Therapy | Neoplasms, Neuroepithelial - pathology | Recovery of Function | Spinal Cord Neoplasms - therapy | temozolomide | SURGERY | astroblastoma | radiation | bevacizumab | spinal cord | oncology | CLINICAL NEUROLOGY | FEATURES
Oncology | Astroblastoma | Spinal cord | Temozolomide | Radiation | Bevacizumab | Neoplasms, Neuroepithelial - therapy | Young Adult | Neoplasms, Neuroepithelial - diagnosis | Diagnosis, Differential | Humans | Spinal Cord Neoplasms - diagnosis | Female | Spinal Cord Neoplasms - pathology | Combined Modality Therapy | Neoplasms, Neuroepithelial - pathology | Recovery of Function | Spinal Cord Neoplasms - therapy | temozolomide | SURGERY | astroblastoma | radiation | bevacizumab | spinal cord | oncology | CLINICAL NEUROLOGY | FEATURES
Journal Article
World Neurosurgery, ISSN 1878-8750, 11/2018, Volume 119, pp. 242 - 243
Rosette-forming glioneuronal tumor has recently been included in the World Health Organization classification as a low-grade tumor. It usually occurs in young...
Spinal | Rosette-forming glioneuronal tumor | Tumor | MRI | RGNT | SURGERY | CLINICAL NEUROLOGY | Spinal Cord Neoplasms - diagnostic imaging | Diagnosis, Differential | Glioma - diagnostic imaging | Glioma - pathology | Humans | Spinal Cord Neoplasms - surgery | Adult | Female | Spinal Cord Neoplasms - pathology | Glioma - surgery | Tumors
Spinal | Rosette-forming glioneuronal tumor | Tumor | MRI | RGNT | SURGERY | CLINICAL NEUROLOGY | Spinal Cord Neoplasms - diagnostic imaging | Diagnosis, Differential | Glioma - diagnostic imaging | Glioma - pathology | Humans | Spinal Cord Neoplasms - surgery | Adult | Female | Spinal Cord Neoplasms - pathology | Glioma - surgery | Tumors
Journal Article
Neuro-Oncology, ISSN 1522-8517, 07/2016, Volume 18, Issue 7, pp. 902 - 913
Ependymomas are rare primary tumors of the central nervous system in children and adults that comprise histologically similar but genetically distinct...
ependymoma | Collaborative Ependymoma Research Network | rare disease | management | molecular classification | ADULT PATIENTS | PROGNOSTIC-FACTORS | MALIGNANT BRAIN-TUMORS | REFRACTORY EPENDYMOMA | SPINAL MYXOPAPILLARY EPENDYMOMAS | CLINICAL NEUROLOGY | POSTOPERATIVE CHEMOTHERAPY | IMMUNOHISTOCHEMICAL MARKERS | ONCOLOGY | INFRATENTORIAL EPENDYMOMA | CENTRAL-NERVOUS-SYSTEM | INTRACRANIAL EPENDYMOMA | Glioma, Subependymal - pathology | Animals | Humans | Brain Neoplasms - pathology | Spinal Cord Neoplasms - diagnosis | Brain Neoplasms - genetics | Quality of Life | Ependymoma - pathology | Spinal Cord Neoplasms - pathology | Ependymoma - genetics | Glioma, Subependymal - genetics | Disease Models, Animal | Invited Reviews
ependymoma | Collaborative Ependymoma Research Network | rare disease | management | molecular classification | ADULT PATIENTS | PROGNOSTIC-FACTORS | MALIGNANT BRAIN-TUMORS | REFRACTORY EPENDYMOMA | SPINAL MYXOPAPILLARY EPENDYMOMAS | CLINICAL NEUROLOGY | POSTOPERATIVE CHEMOTHERAPY | IMMUNOHISTOCHEMICAL MARKERS | ONCOLOGY | INFRATENTORIAL EPENDYMOMA | CENTRAL-NERVOUS-SYSTEM | INTRACRANIAL EPENDYMOMA | Glioma, Subependymal - pathology | Animals | Humans | Brain Neoplasms - pathology | Spinal Cord Neoplasms - diagnosis | Brain Neoplasms - genetics | Quality of Life | Ependymoma - pathology | Spinal Cord Neoplasms - pathology | Ependymoma - genetics | Glioma, Subependymal - genetics | Disease Models, Animal | Invited Reviews
Journal Article
14.
Full Text
Pathology of Spinal Ependymomas: An Institutional Experience Over 25 Years in 134 Patients
Neurosurgery, ISSN 0148-396X, 08/2013, Volume 73, Issue 2, pp. 247 - 255
BACKGROUND:Ependymomas constitute approximately 40% of primary intraspinal tumors. Current World Health Organization (WHO) grading may not correlate with...
Myxopapillary | Adjuvant radiation | Classic | Spine | Ependymoma | SURVIVAL | SURGERY | STEM-CELLS | MYXOPAPILLARY EPENDYMOMAS | PROGNOSIS | FOLLOW-UP | CORD EPENDYMOMAS | TUMORS | CLINICAL NEUROLOGY | CHILDREN | OUTCOMES | AGE | Prognosis | Humans | Middle Aged | Male | Ependymoma - therapy | Neoplasm Recurrence, Local - pathology | Young Adult | Neurosurgical Procedures | Neoplasm Grading | Ependymoma - mortality | Adult | Ependymoma - pathology | Female | Retrospective Studies | Radiotherapy, Adjuvant | Child | Spinal Cord Neoplasms - therapy | Kaplan-Meier Estimate | Treatment Outcome | Disease-Free Survival | Magnetic Resonance Imaging | Spinal Cord Neoplasms - mortality | Adolescent | Spinal Cord Neoplasms - pathology | Aged | Neoplasm Recurrence, Local - epidemiology
Myxopapillary | Adjuvant radiation | Classic | Spine | Ependymoma | SURVIVAL | SURGERY | STEM-CELLS | MYXOPAPILLARY EPENDYMOMAS | PROGNOSIS | FOLLOW-UP | CORD EPENDYMOMAS | TUMORS | CLINICAL NEUROLOGY | CHILDREN | OUTCOMES | AGE | Prognosis | Humans | Middle Aged | Male | Ependymoma - therapy | Neoplasm Recurrence, Local - pathology | Young Adult | Neurosurgical Procedures | Neoplasm Grading | Ependymoma - mortality | Adult | Ependymoma - pathology | Female | Retrospective Studies | Radiotherapy, Adjuvant | Child | Spinal Cord Neoplasms - therapy | Kaplan-Meier Estimate | Treatment Outcome | Disease-Free Survival | Magnetic Resonance Imaging | Spinal Cord Neoplasms - mortality | Adolescent | Spinal Cord Neoplasms - pathology | Aged | Neoplasm Recurrence, Local - epidemiology
Journal Article